What is the clinical evidence from this study?

Study design: Cohort. Population: Sudden cardiac death (n=23). Intervention: Myocardial revascularization and AICD implantation. Primary outcome: Two-year survival.

What does this research mean for the field?

Combined myocardial revascularization and automatic implantable cardioverter defibrillator (AICD) implantation in survivors of sudden cardiac death yields a high two-year survival rate of 91%. Novelty: ClaimNovelty.INCREMENTAL. Consensus alignment: ConsensusAlignment.NEUTRAL.

July 1, 1988The Annals of Thoracic SurgeryOpen Access

Impending Sudden Cardiac Death: Treatment with Myocardial Revascularization and the Automatic Implantable Cardioverter Defibrillator

View Full Paper

Ask AI

Bookmark

Key result

Combined revascularization and AICD implantation yields ~91% two-year survival in sudden cardiac death survivors.

n=23

Why the study?

The combined role of myocardial revascularization and AICD implantation in improving survival after sudden cardiac death has not been well defined.

Does combined myocardial revascularization and AICD implantation improve survival in survivors of sudden cardiac death?

Comparison

Combined myocardial revascularization and AICD implantation

Design

Cohort study

Follow-up

Average 24 months

Authors

JFJames D. FongerBoston University TGThomas GuarnieriDepartment of Public Health LGLawrence S.C. GriffithSouth Australian Health and Medical Research Institute

Discussion

Member takes

Implication

Supports combined revascularization and AICD in sudden cardiac death survivors; leaves open survival benefit versus standard care in controlled trials.

Study Design

Type

Cohort (n=23)

Structured PICO

Does combined myocardial revascularization and AICD implantation improve survival in survivors of sudden cardiac death?

Population

23 survivors of sudden cardiac death who underwent myocardial revascularization and AICD implantation, followed for an average of 24 months.

Exposure

Combined myocardial revascularization and automatic implantable cardioverter defibrillator (AICD) implantation.

Outcome

Survival at two yearshard clinical

Combined myocardial revascularization and AICD implantation yields a high two-year survival rate (91%) in survivors of sudden cardiac death, though a significant proportion require AICD resuscitation.

Cite This Study

Fonger et al. (1988) conducted a cohort in Sudden cardiac death (n=23). Myocardial revascularization and AICD implantation was evaluated on Two-year survival. Combined myocardial revascularization and AICD implantation in survivors of sudden cardiac death resulted in a two-year survival rate of 91%.

synapsesocial.com/papers/6ab88f3b6d9b6fc8d8a13202 https://doi.org/10.1016/s0003-4975(10)65843-2

View Full Paper

Ask AI

Bookmark

Implication

Supports combined revascularization and AICD in sudden cardiac death survivors; leaves open survival benefit versus standard care in controlled trials.

Impending Sudden Cardiac Death: Treatment with Myocardial Revascularization and the Automatic Implantable Cardioverter Defibrillator

Discussion

Member takes

Implication

Study Design

Structured PICO

Cite This Study

Impending Sudden Cardiac Death: Treatment with Myocardial Revascularization and the Automatic Implantable Cardioverter Defibrillator

Discussion

Member takes

Implication

Study Design

Structured PICO

Cite This Study

Also Consider

Also Consider